Overview
The study is designed to evaluate if the COVID-19 vaccine reduces COVID-19 disease as compared to placebo given to healthy adults 50 to 64 years of age. Approximately 25,500 participants will be randomly chosen to get either one dose of COVID-19 vaccine or of a placebo.
Principal investigator
Eligibility criteria
Key Inclusion Criteria
* People who are between 50 and 64 years old at their first appointment.
* People who are healthy and, based on their medical history and a doctor's judgment, are considered suitable to join the study. Key Exclusion Criteria
* People who had COVID-19 in the past 3 months (90 days) before their first visit.
* People who got a COVID-19 vaccine, either as part of a research study or an approved vaccine, in the last 3 months-or plans to get one during the study.
* People who are between 50 and 64 years old at their first appointment.
* People who are healthy and, based on their medical history and a doctor's judgment, are considered suitable to join the study. Key Exclusion Criteria
* People who had COVID-19 in the past 3 months (90 days) before their first visit.
* People who got a COVID-19 vaccine, either as part of a research study or an approved vaccine, in the last 3 months-or plans to get one during the study.
For Referring Providers
Do you have a patient you think would be a good candidate for this trial? Learn more about enrolling your patient.